IDH1 and neoplasm: Indeed several clinical studies are investigating the utility of these inhibitors, and although mutant IDH has been shown to play its most critical role in tumor initiation,40 results to date show some objective responses, including after BAY-1436032 treatment, as well as an increase in cases of stable disease associated with enhanced survival.